DAPK1 and B-cell non-Hodgkin lymphoma: For example, tissue factor pathway inhibitor-2 (TFPI-2) is hypermethylated in its promoter region, decreasing its expression [72], and death-associated protein kinase (DAPK) hypermethylation has been correlated to negative prognosis in canine B-cell lymphoma [73].